Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage | Zendy

TzeFan Chao | Zendy; ChiaJen Liu | Zendy; JoNan Liao | Zendy; Kang-Ling Wang | Zendy; YennJiang Lin | Zendy; ShihLin Chang | Zendy; LiWei Lo | Zendy; YuFeng Hu | Zendy; TaChuan Tuan | Zendy; FaPo Chung | Zendy; TzengJi Chen | Zendy; Gregory Y.H. Lip | Zendy; ShihAnn Chen | Zendy

Open Access

Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage

Author(s) -

TzeFan Chao,

ChiaJen Liu,

JoNan Liao,

Kang-Ling Wang,

YennJiang Lin,

ShihLin Chang,

LiWei Lo,

YuFeng Hu,

TaChuan Tuan,

FaPo Chung,

TzengJi Chen,

Gregory Y.H. Lip,

ShihAnn Chen

Publication year - 2016

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.115.019794

Subject(s) - medicine , atrial fibrillation , warfarin , antithrombotic , stroke (engine) , cardiology , mechanical engineering , engineering

The risk of further intracranial hemorrhage (ICH) and the benefit of stroke risk reduction with the use of oral anticoagulants for patients who have atrial fibrillation with a history of ICH remain unclear. We aimed to investigate the risks and benefits in patients who have atrial fibrillation with a previous ICH treated with warfarin or antiplatelet drugs in comparison with no antithrombotic therapies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research